| SEC entity type | operating | 2026-11-04 | SEC EDGAR company profile | 2026-11-22 00:59 UTC | Report an error |
|---|
| SIC industry | 2844 Perfumes, Cosmetics & Other Toilet Preparations | 2026-11-04 | SEC EDGAR company profile | 2026-11-22 00:59 UTC | Report an error |
|---|
| State of incorporation | NC | 2026-11-04 | SEC EDGAR company profile | 2026-11-22 00:59 UTC | Report an error |
|---|
| Fiscal year end (MMDD) | 0930 | 2026-11-04 | SEC EDGAR company profile | 2026-11-22 00:59 UTC | Report an error |
|---|
| Business address | 2101 WESTINGHOUSE BLVD., SUITE A, CHARLOTTE, NC, 28273 | 2026-11-04 | SEC EDGAR company profile | 2026-11-22 00:59 UTC | Report an error |
|---|
| Exchanges | NYSE | 2026-11-04 | SEC EDGAR company profile | 2026-11-22 00:59 UTC | Report an error |
|---|
| Revenue (fiscal year ended 2025-09-30) | $19,190,468 | 2025-09-30 | 10-K, XBRL Revenues | 2026-11-22 00:59 UTC | Report an error |
|---|
| Net income (loss) (fiscal year ended 2025-09-30) | $-2,040,902 | 2025-09-30 | 10-K, XBRL NetIncomeLoss | 2026-11-22 00:59 UTC | Report an error |
|---|
| Total assets (at 2025-09-30) | $10,419,950 | 2025-09-30 | 10-K, XBRL Assets | 2026-11-22 00:59 UTC | Report an error |
|---|
| Stockholders' equity (at 2025-09-30) | $7,226,107 | 2025-09-30 | 10-K, XBRL StockholdersEquity | 2026-11-22 00:59 UTC | Report an error |
|---|
| Cash and cash equivalents (at 2025-09-30) | $2,261,242 | 2025-09-30 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | 2026-11-22 00:59 UTC | Report an error |
|---|
| Operating cash flow (fiscal year ended 2025-09-30) | $-1,452,375 | 2025-09-30 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | 2026-11-22 00:59 UTC | Report an error |
|---|
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-09-30) | $184,172 | 2025-09-30 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | 2026-11-22 00:59 UTC | Report an error |
|---|
| Remaining performance obligation (at 2025-09-30) | $0 | 2025-09-30 | 10-K, XBRL RevenueRemainingPerformanceObligation | 2026-11-22 00:59 UTC | Report an error |
|---|
| Operating lease liabilities (at 2025-09-30) | $778,240 | 2025-09-30 | 10-K, XBRL OperatingLeaseLiability | 2026-11-22 00:59 UTC | Report an error |
|---|
| Form D total offering amount (D/A filed 2016-09-27) | $2,500,000 | 2016-09-27 | D/A | 2026-11-22 00:59 UTC | Report an error |
|---|
| Form D total amount sold (D/A filed 2016-09-27) | $0 | 2016-09-27 | D/A | 2026-11-22 00:59 UTC | Report an error |
|---|
| Form D industry group | Other | 2016-09-27 | D/A | 2026-11-22 00:59 UTC | Report an error |
|---|
| Form D revenue range | Decline to Disclose | 2016-09-27 | D/A | 2026-11-22 00:59 UTC | Report an error |
|---|
| 8-K Item 2.01, Completion of Acquisition or Disposition of Assets (filed 2026-11-04) | As previously reported in the Current Report on Form 8-K filed by cbdMD, Inc. (the “Company”) with the Securities and Exchange Commission (the “SEC”), on September 2, 2026, the Company entered into an Asset Purchase Agreement (the “APA”) dated September 1, 2026 by and among the Company, To Be Brands, LLC, a North Carolina limited liability company and wholly owned subsidiary of the Company (the “Acquisition Sub”), Twinlab Consolidated Holdings, Inc., a Nevada corporation (“Twinlab”), the wholly owned direct and indirect subsidiaries of Twinlab set forth in the APA (the “Assignors”), Philip J. Von Kahle, in his capacity as the duly appointed assignee for the benefit of creditors of each of… | 2026-11-04 | SEC EDGAR 8-K 0001437749-26-034991 (text as filed, excerpt) | 2026-11-22 00:59 UTC | Report an error |
|---|
| 8-K Item 2.03, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (filed 2026-11-04) | On the Closing Date, in connection with the Acquisition, the Acquisition Sub and the Acquired Subsidiaries issued a Senior Secured Promissory Note to the Secured Creditor in the principal amount of $1,750,000 (the “Note”), evidencing the Assumed Debt. The Note bears interest at a rate of 9% per annum and matures two years following the Closing Date. The Note is secured by the Acquired Assets pursuant to a Senior Security Agreement among the Acquisition Sub, the Acquired Subsidiaries and the Secured Creditor (the “Security Agreement”). The foregoing descriptions of the Note and the Security Agreement do not purport to be complete and are qualified in their entirety by reference to the full… | 2026-11-04 | SEC EDGAR 8-K 0001437749-26-034991 (text as filed, excerpt) | 2026-11-22 00:59 UTC | Report an error |
|---|
| 8-K Item 3.02, Unregistered Sales of Equity Securities (filed 2026-11-04) | The information set forth in Item 2.01 above regarding the Common Stock Consideration is incorporated by reference into this Item 3.02. On the Closing Date, the Company issued the Common Stock Consideration to the Secured Creditor in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or Regulation D promulgated thereunder, based in part on the representations of the Secured Creditor that it is an “accredited investor” as defined in Rule 501(a) of Regulation D. The shares of common stock comprising the Common Stock Consideration have not been registered under the Securities Act and may not be offered… | 2026-11-04 | SEC EDGAR 8-K 0001437749-26-034991 (text as filed, excerpt) | 2026-11-22 00:59 UTC | Report an error |
|---|
| 8-K Item 7.01, Regulation FD Disclosure (filed 2026-11-04) | On November 2, 2026, the Company issued a press release announcing the completion of the Acquisition. A copy of the press release is attached as Exhibit 99.1 hereto and incorporated by reference herein. The information set forth in this Item 7.01 and in the press release attached hereto as Exhibit 99.1, is deemed to be “furnished” and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information set forth in this Item 7.01, including Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities… | 2026-11-04 | SEC EDGAR 8-K 0001437749-26-034991 (text as filed, excerpt) | 2026-11-22 00:59 UTC | Report an error |
|---|
| 8-K Item 8.01, Other Events (filed 2026-11-04) | As described in Item 2.01 above, the Acquired Assets consist primarily of intellectual property, assigned contracts, permits, tangible personal property, inventory, accounts receivable and goodwill used in the Assignors’ business, together with all of the outstanding equity interests of the Acquired Subsidiaries (ISI Brands, Inc., Reserve Life Organics, LLC, Innovitamin Organics, LLC and Resvitale, LLC), each of which became a wholly owned subsidiary of the Acquisition Sub upon the closing of the Acquisition. Twinlab is a marketer, distributor, and direct-to-consumer retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food… | 2026-11-04 | SEC EDGAR 8-K 0001437749-26-034991 (text as filed, excerpt) | 2026-11-22 00:59 UTC | Report an error |
|---|
| 8-K Item 1.01, Entry into a Material Definitive Agreement (filed 2026-09-02) | On September 1, 2026, cbdMD, Inc. (the “Company”) entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) by and among the Company, To Be Brands, LLC, a North Carolina limited liability company and wholly owned subsidiary of the Company, Twinlab Consolidated Holdings, Inc., a Nevada corporation (“Twinlab”), the wholly owned direct and indirect subsidiaries of Twinlab set forth in the Asset Purchase Agreement (the “Assignors”), Philip J. Von Kahle, in his capacity as the duly appointed assignee for the benefit of creditors of each of the Assignors under a General Assignment for the Benefit of Creditors dated August 21, 2026 (the “Assignee”), and Akretive Holdings, LLC, a… | 2026-09-02 | SEC EDGAR 8-K 0001437749-26-029455 (text as filed, excerpt) | 2026-11-22 00:59 UTC | Report an error |
|---|
| 8-K Item 5.03, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (filed 2026-09-02) | On September 29, 2025, the Company filed a Certificate of Amendment to the Certificate of Incorporation (the “Certificate of Designation”) designating 1,700,000 shares of the Company’s authorized preferred stock as Series B Convertible Preferred Stock (the “Series B”). Each share of the Series B was initially convertible into common stock at a conversion price of $1.00, subject to anti-dilution and other adjustment rights and preferences as defined in the Certificate of Designation. Effective September 2, 2026, the Company filed an amendment to the Certificate of Designation reducing the conversion price to $0.60 per share. There are currently 591,207 shares of Series B issued and… | 2026-09-02 | SEC EDGAR 8-K 0001437749-26-029455 (text as filed, excerpt) | 2026-11-22 00:59 UTC | Report an error |
|---|
| 8-K Item 7.01, Regulation FD Disclosure (filed 2026-09-02) | On September 2, 2026, in connection with the execution of the Asset Purchase Agreement, the Company issued the press release attached as Exhibit 99.1 hereto and incorporated by reference herein. The information set forth in this Item 7.01 and in the press release attached hereto as Exhibit 99.1, is deemed to be “furnished” and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information set forth in this Item 7.01, including Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of… | 2026-09-02 | SEC EDGAR 8-K 0001437749-26-029455 (text as filed, excerpt) | 2026-11-22 00:59 UTC | Report an error |
|---|
| Largest institutional holder #1 (13F as filed): Worth Venture Partners, LLC | $124,368 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:59 UTC | Report an error |
|---|
| Largest institutional holder #2 (13F as filed): CSS LLC/IL | $92,619 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:59 UTC | Report an error |
|---|
| Largest institutional holder #3 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC | $80,521 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:59 UTC | Report an error |
|---|
| Largest institutional holder #4 (13F as filed): CHAPIN DAVIS, INC. | $54,681 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:59 UTC | Report an error |
|---|
| Largest institutional holder #5 (13F as filed): Alesco Advisors, LLC, An ESL Co | $46,109 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:59 UTC | Report an error |
|---|
| Largest institutional holder #6 (13F as filed): Chicago Partners Investment Group LLC | $45,008 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:59 UTC | Report an error |
|---|
| Largest institutional holder #7 (13F as filed): XTX Topco Ltd | $42,226 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:59 UTC | Report an error |
|---|
| Largest institutional holder #8 (13F as filed): JANE STREET GROUP, LLC | $36,612 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:59 UTC | Report an error |
|---|
| Largest institutional holder #9 (13F as filed): VANGUARD FIDUCIARY TRUST CO | $31,737 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:59 UTC | Report an error |
|---|
| Largest institutional holder #10 (13F as filed): UBS Group AG | $14,520 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 00:59 UTC | Report an error |
|---|